B Asselain

1.1k total citations
28 papers, 866 citations indexed

About

B Asselain is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, B Asselain has authored 28 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Epidemiology and 8 papers in Cancer Research. Recurrent topics in B Asselain's work include Breast Cancer Treatment Studies (7 papers), Multiple and Secondary Primary Cancers (6 papers) and Cancer Treatment and Pharmacology (5 papers). B Asselain is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Multiple and Secondary Primary Cancers (6 papers) and Cancer Treatment and Pharmacology (5 papers). B Asselain collaborates with scholars based in France. B Asselain's co-authors include P Pouillart, Alain Fourquet, Anne de la Rochefordière, J. Durand, F. Campana, J Fenton, J.R. Vilcoq, H Magdelénat, Xavier Sastre‐Garau and Anne Vincent‐Salomon and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

B Asselain

28 papers receiving 828 citations

Peers

B Asselain
Elizabeth Salisbury Australia
Monica Leutner Italy
F. Kommoss Germany
Barbara D. Florentine United States
I. D. Werner South Africa
Allison M. Cushman‐Vokoun United States
Hans‐Christian Kolberg Germany
Nathan Hunkapiller United States
Melissa C. Larson United States
Hadar Goldvaser Israel
Elizabeth Salisbury Australia
B Asselain
Citations per year, relative to B Asselain B Asselain (= 1×) peers Elizabeth Salisbury

Countries citing papers authored by B Asselain

Since Specialization
Citations

This map shows the geographic impact of B Asselain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Asselain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Asselain more than expected).

Fields of papers citing papers by B Asselain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Asselain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Asselain. The network helps show where B Asselain may publish in the future.

Co-authorship network of co-authors of B Asselain

This figure shows the co-authorship network connecting the top 25 collaborators of B Asselain. A scholar is included among the top collaborators of B Asselain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Asselain. B Asselain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tourneau, C. Le, Brigitte Dréno, Youlia Kirova, et al.. (2016). First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma. British Journal of Cancer. 114(11). 1199–1205. 30 indexed citations
2.
Lerebours, F., Delphine Héquet, Sandrine Baffert, et al.. (2016). Abstract OT2-04-01: Optisoins01: Optimizing the patient-breast cancer care pathway; An observational multicentric prospective study. Cancer Research. 76(4_Supplement). OT2–4. 1 indexed citations
3.
4.
Berger, Frédérique, et al.. (2011). Impact du statut socioéconomique sur la gravité du diagnostic initial de cancer du sein. Revue d Épidémiologie et de Santé Publique. 60(1). 19–29. 14 indexed citations
5.
Majed, Bilal, Thomas Moreau, Kamel Senouci, et al.. (2009). Corpulence et pronostic du cancer du sein non métastatique de la femme: résultats d'une étude de cohorte observationnelle française. Bulletin du Cancer. 96(5). 531–541. 6 indexed citations
6.
Thiery, Jean Paul, Xavier Sastre‐Garau, Charles Decraene, et al.. (2006). Challenges in the stratification of breast tumors for tailored therapies.. PubMed. 93(8). E81–9. 8 indexed citations
7.
Vincent‐Salomon, Anne, Chantal Gautier, Brigitte Sigal‐Zafrani, et al.. (2005). Neoadjuvant chemotherapy for invasive lobular carcinomas of the breast: a poorer response rate but not a worse prognosis than invasive ductal carcinoma. Breast Cancer Research and Treatment. 94. 9 indexed citations
8.
9.
Blot, Emmanuel, et al.. (2003). Outbreak of Clostridium difficile -related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. Journal of Hospital Infection. 53(3). 187–192. 60 indexed citations
10.
Genestie, Catherine, et al.. (1998). Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.. PubMed. 18(1B). 571–6. 117 indexed citations
11.
Broët, Philippe, Anne de la Rochefordière, Suzy Scholl, et al.. (1996). [Contralateral breast cancer: metastasis or second primary cancer?].. PubMed. 83(10). 870–6. 8 indexed citations
12.
Rochefordière, Anne de la, F. Campana, J Fenton, et al.. (1993). Age as prognostic factor in premenopausal breast carcinoma. The Lancet. 341(8852). 1039–1043. 397 indexed citations
13.
Brunin, F, Juan Carlos de Vicente, C Jaulerry, et al.. (1992). [Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].. PubMed. 79(9). 893–904. 3 indexed citations
14.
Plu‐Bureau, Geneviève, et al.. (1992). Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. British Journal of Cancer. 65(6). 945–949. 37 indexed citations
15.
Fenton, J, Sylvie Chevret, B Asselain, et al.. (1990). [Invasive cancer of the uterine cervix in young women: retrospective study of 236 cases].. PubMed. 77(2). 109–16. 6 indexed citations
16.
Brunin, F, José Rodríguez, C Jaulerry, et al.. (1989). Induction Chemotherapy in Advanced Head and Neck Cancer Preliminary results of a randomized study. Acta Oncologica. 28(1). 61–65. 23 indexed citations
17.
Garnier, Philippe, et al.. (1988). [Prognostic value of the Lauren and Ming classifications in gastric adenocarcinoma. Multidimensional analysis].. PubMed. 12(6-7). 553–8. 8 indexed citations
18.
Pennehouat, G, Véronique Mosseri, J.C. Durand, et al.. (1988). [Lymphoceles and peritonization following lymphadenectomy for cancer of the uterus].. PubMed. 17(3). 373–8. 16 indexed citations
19.
Jouve, M, T Palangié, Thierry Dorval, et al.. (1987). [Metastatic breast cancer. Modality of association of chemotherapy and hormonotherapy. Results of a controlled trial].. PubMed. 74(3). 249–60. 4 indexed citations
20.
Pouillart, P, et al.. (1982). [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].. PubMed. 69(5). 461–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Salisbury Breakdown of academic impact, for papers by Monica Leutner Breakdown of academic impact, for papers by F. Kommoss Breakdown of academic impact, for papers by Barbara D. Florentine Breakdown of academic impact, for papers by I. D. Werner Breakdown of academic impact, for papers by Allison M. Cushman‐Vokoun Breakdown of academic impact, for papers by Hans‐Christian Kolberg Breakdown of academic impact, for papers by Nathan Hunkapiller Breakdown of academic impact, for papers by Melissa C. Larson Breakdown of academic impact, for papers by Hadar Goldvaser
Rankless by CCL
2026